Policy & Sector Insights

Reuters
In an effort to increase competition and bring down prescription drug prices, FDA Commissioner Dr. Scott Gottlieb wants to speed approval times for rivals to promising new first-to-market medicines…Read More.

STAT News
Pharmacy benefit managers, which long ran under the public radar, now have President Trump’s attention. In a recent speech on drug pricing, he called out “the dishonest double-dealing that allows the middleman to pocket rebates and discounts that should be passed on to consumers and patients.”Read More.

Kaiser Health News
Guess who’s back grabbing headlines? Pharmacy benefit managers — those companies that serve as middlemen in the prescription drug pipeline…Read More.

WILX 10
A Michigan lawmaker wants to give pharmacists the right to disclose the actual price they paid for a drug…Read More.

Orlando Sentinel
Americans spend more per capita on prescription drugs than any other high-income country in the world. Many states have wrestled with the rising costs of these medications, particularly in Florida…Read More.

ABC News
People are often overpaying for prescription drugs when they are charged the insurance copay at the pharmacy, according to a new study from the University of Southern California…Read More.

Huffington Post
It’s hard to remember now, but there once was a time when pharmaceutical companies were considered heroes, not villains…Read More.

Axios
After months of circular finger-pointing over high drug prices, lawmakers, administration officials and parts of the health care industry seem to have settled on an initial target: pharmacy benefit managers, the middlemen that health insurers and employers hire to negotiate with drug companies…Read More.

STAT
When the patent on a brand-name drug expires, and one or more generic versions enter the market, you’d expect consumers to pay less for the generic. That isn’t necessarily the case, thanks to the middlemen known as pharmacy benefit managers…Read More.